Protective effect of Dexrazoxane on Epirubicin cardiotoxicity in the elderly patients with breast cancer

Protective effect of Dexrazoxane on Epirubicin cardiotoxicity in the elderly patients with breast cancer

Objective To observe the preventive and therapeutic effects of dexrazoxane (Dexrazoxane, DEX) against the cardiac toxicity induced by epirubicin(Epirubicin, EPI) in the elderly patients with breast cancer. Methods The elderly patients with breast cancer from 2008.5-2011.11 were enrolled, all the pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese Journal of Cardivascular Research/Zhongguo Xinxueguanbing Yanjiu 2014-05, Vol.12 (5), p.475-478
Hauptverfasser: ZHAO, Chu-min, ZHAO, Gang, WANG, Yue
Format: Artikel
Sprache:chi
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 478
container_issue 5
container_start_page 475
container_title Chinese Journal of Cardivascular Research/Zhongguo Xinxueguanbing Yanjiu
container_volume 12
creator ZHAO, Chu-min
ZHAO, Gang
WANG, Yue
description Objective To observe the preventive and therapeutic effects of dexrazoxane (Dexrazoxane, DEX) against the cardiac toxicity induced by epirubicin(Epirubicin, EPI) in the elderly patients with breast cancer. Methods The elderly patients with breast cancer from 2008.5-2011.11 were enrolled, all the patients were receipted the chemotherapy regimen of TE (Epirubicin+Docetaxel) or CEF (Epirubicin+Cyclophosphamide+Fluorouracil), and whose age were equal or greater than 65 years old. All the patients were randomly assigned to be treated with(42 patients) or without(42 patients) Dexrazoxane. All of the patients were continuous follow-up in 2 years, and the cardiac troponin T (TNT) and left ventricular ejection fraction (LVEF) were measured. Results The increase of the TNT and the decrease of the LVEF in the treatment group were lower than those of the control group (P0.05). Conclusion The cardiac toxicity had been production from the
doi_str_mv 10.3969/j.issn.1672-5301.2014.05.023
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1560116991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1560116991</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_15601169913</originalsourceid><addsrcrecordid>eNqVjbFOxDAQRF2AxAnuH7agoDljJ5dYqeEQJQX9yfFtlEXBDt4N5Ph6XCB6qpl5mtEodWuNrru2u3_TxBy1bV21a2pjdWXsXptGm6q-UJs_fqW2zNQb6_bOGVdt1PiSk2AQ-kTAYSgO0gCPuGb_nVYfEVKEw0x56SlQhODziZKktSQ5QyEyluV0wjydYfZCGIXhi2SEPqNnKZMYMN-oy8FPjNtfvVZ3T4fXh-fdnNPHgizHd-KA01Q-08JH27TG2rbrbP2P6g94y1Va</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560116991</pqid></control><display><type>article</type><title>Protective effect of Dexrazoxane on Epirubicin cardiotoxicity in the elderly patients with breast cancer</title><source>Alma/SFX Local Collection</source><creator>ZHAO, Chu-min ; ZHAO, Gang ; WANG, Yue</creator><creatorcontrib>ZHAO, Chu-min ; ZHAO, Gang ; WANG, Yue</creatorcontrib><description>Objective To observe the preventive and therapeutic effects of dexrazoxane (Dexrazoxane, DEX) against the cardiac toxicity induced by epirubicin(Epirubicin, EPI) in the elderly patients with breast cancer. Methods The elderly patients with breast cancer from 2008.5-2011.11 were enrolled, all the patients were receipted the chemotherapy regimen of TE (Epirubicin+Docetaxel) or CEF (Epirubicin+Cyclophosphamide+Fluorouracil), and whose age were equal or greater than 65 years old. All the patients were randomly assigned to be treated with(42 patients) or without(42 patients) Dexrazoxane. All of the patients were continuous follow-up in 2 years, and the cardiac troponin T (TNT) and left ventricular ejection fraction (LVEF) were measured. Results The increase of the TNT and the decrease of the LVEF in the treatment group were lower than those of the control group (P&lt;0.05). The toxic reaction and the cardiac events in two groups were no difference (P&gt;0.05). Conclusion The cardiac toxicity had been production from the</description><identifier>ISSN: 1672-5301</identifier><identifier>DOI: 10.3969/j.issn.1672-5301.2014.05.023</identifier><language>chi</language><ispartof>Chinese Journal of Cardivascular Research/Zhongguo Xinxueguanbing Yanjiu, 2014-05, Vol.12 (5), p.475-478</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>ZHAO, Chu-min</creatorcontrib><creatorcontrib>ZHAO, Gang</creatorcontrib><creatorcontrib>WANG, Yue</creatorcontrib><title>Protective effect of Dexrazoxane on Epirubicin cardiotoxicity in the elderly patients with breast cancer</title><title>Chinese Journal of Cardivascular Research/Zhongguo Xinxueguanbing Yanjiu</title><description>Objective To observe the preventive and therapeutic effects of dexrazoxane (Dexrazoxane, DEX) against the cardiac toxicity induced by epirubicin(Epirubicin, EPI) in the elderly patients with breast cancer. Methods The elderly patients with breast cancer from 2008.5-2011.11 were enrolled, all the patients were receipted the chemotherapy regimen of TE (Epirubicin+Docetaxel) or CEF (Epirubicin+Cyclophosphamide+Fluorouracil), and whose age were equal or greater than 65 years old. All the patients were randomly assigned to be treated with(42 patients) or without(42 patients) Dexrazoxane. All of the patients were continuous follow-up in 2 years, and the cardiac troponin T (TNT) and left ventricular ejection fraction (LVEF) were measured. Results The increase of the TNT and the decrease of the LVEF in the treatment group were lower than those of the control group (P&lt;0.05). The toxic reaction and the cardiac events in two groups were no difference (P&gt;0.05). Conclusion The cardiac toxicity had been production from the</description><issn>1672-5301</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqVjbFOxDAQRF2AxAnuH7agoDljJ5dYqeEQJQX9yfFtlEXBDt4N5Ph6XCB6qpl5mtEodWuNrru2u3_TxBy1bV21a2pjdWXsXptGm6q-UJs_fqW2zNQb6_bOGVdt1PiSk2AQ-kTAYSgO0gCPuGb_nVYfEVKEw0x56SlQhODziZKktSQ5QyEyluV0wjydYfZCGIXhi2SEPqNnKZMYMN-oy8FPjNtfvVZ3T4fXh-fdnNPHgizHd-KA01Q-08JH27TG2rbrbP2P6g94y1Va</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>ZHAO, Chu-min</creator><creator>ZHAO, Gang</creator><creator>WANG, Yue</creator><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20140501</creationdate><title>Protective effect of Dexrazoxane on Epirubicin cardiotoxicity in the elderly patients with breast cancer</title><author>ZHAO, Chu-min ; ZHAO, Gang ; WANG, Yue</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_15601169913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2014</creationdate><toplevel>online_resources</toplevel><creatorcontrib>ZHAO, Chu-min</creatorcontrib><creatorcontrib>ZHAO, Gang</creatorcontrib><creatorcontrib>WANG, Yue</creatorcontrib><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Chinese Journal of Cardivascular Research/Zhongguo Xinxueguanbing Yanjiu</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZHAO, Chu-min</au><au>ZHAO, Gang</au><au>WANG, Yue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protective effect of Dexrazoxane on Epirubicin cardiotoxicity in the elderly patients with breast cancer</atitle><jtitle>Chinese Journal of Cardivascular Research/Zhongguo Xinxueguanbing Yanjiu</jtitle><date>2014-05-01</date><risdate>2014</risdate><volume>12</volume><issue>5</issue><spage>475</spage><epage>478</epage><pages>475-478</pages><issn>1672-5301</issn><abstract>Objective To observe the preventive and therapeutic effects of dexrazoxane (Dexrazoxane, DEX) against the cardiac toxicity induced by epirubicin(Epirubicin, EPI) in the elderly patients with breast cancer. Methods The elderly patients with breast cancer from 2008.5-2011.11 were enrolled, all the patients were receipted the chemotherapy regimen of TE (Epirubicin+Docetaxel) or CEF (Epirubicin+Cyclophosphamide+Fluorouracil), and whose age were equal or greater than 65 years old. All the patients were randomly assigned to be treated with(42 patients) or without(42 patients) Dexrazoxane. All of the patients were continuous follow-up in 2 years, and the cardiac troponin T (TNT) and left ventricular ejection fraction (LVEF) were measured. Results The increase of the TNT and the decrease of the LVEF in the treatment group were lower than those of the control group (P&lt;0.05). The toxic reaction and the cardiac events in two groups were no difference (P&gt;0.05). Conclusion The cardiac toxicity had been production from the</abstract><doi>10.3969/j.issn.1672-5301.2014.05.023</doi></addata></record>
fulltext fulltext
identifier ISSN: 1672-5301
ispartof Chinese Journal of Cardivascular Research/Zhongguo Xinxueguanbing Yanjiu, 2014-05, Vol.12 (5), p.475-478
issn 1672-5301
language chi
recordid cdi_proquest_miscellaneous_1560116991
source Alma/SFX Local Collection
title Protective effect of Dexrazoxane on Epirubicin cardiotoxicity in the elderly patients with breast cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A19%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protective%20effect%20of%20Dexrazoxane%20on%20Epirubicin%20cardiotoxicity%20in%20the%20elderly%20patients%20with%20breast%20cancer&rft.jtitle=Chinese%20Journal%20of%20Cardivascular%20Research/Zhongguo%20Xinxueguanbing%20Yanjiu&rft.au=ZHAO,%20Chu-min&rft.date=2014-05-01&rft.volume=12&rft.issue=5&rft.spage=475&rft.epage=478&rft.pages=475-478&rft.issn=1672-5301&rft_id=info:doi/10.3969/j.issn.1672-5301.2014.05.023&rft_dat=%3Cproquest%3E1560116991%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1560116991&rft_id=info:pmid/&rfr_iscdi=true